Physician profile
Andrea Tabbert
NPI 1063048049
$525.48
in general payments reported to CMS, 2019-2025
14 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.84 · 2022: $202 · 2023: $54.87 · 2024: $58.28 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $122.38 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.90 | 2025 | |
| Vericel Corporation | $53.08 | 2023-2024 | Nexobrid |
| Novo Nordisk INC | $44.62 | 2022 | |
| Abbvie INC. | $42.02 | 2022 | |
| Horizon Therapeutics Plc | $37.38 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $23.50 | 2022 | |
| Grt US Holding, INC. | $23.21 | 2022 | |
| Integra Lifesciences Corporation | $22.20 | 2023 | Tenoglide |
| Acera Surgical, INC. | $19.99 | 2024 | Restrata Wound Matrix |
| Ethicon US, LLC | $17.88 | 2024 | Megadyne |
| Aroa Biosurgery Incorporated | $17.53 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.90 | 2022 | |
| Nevro Corp. | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Tabbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.